The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

Britain's GSK is set to acquire RAPT Therapeutics for $2.2 billion. This move brings the experimental food allergy drug ozureprubart into G...

British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion paymen...

The IPO comprises fresh equity issue worth up to Rs 750 crore and offer for sale (OFS) of up to 2.93 crore equity shares by existing invest...

The drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company ...

Existing shareholders who are looking at selling part of their stake include Carlyle, Singapore-based venture capital fund Genesis Alternat...

The proposed transaction pertains to acquisition of 100 per cent of the equity shareholding of Parexel International, according to a notice...

The US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.

For Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...

Competition Commission of India (CCI) has approved Japanese firm Mitsui's proposed takeover of 26.71 per cent stake in domestic biopharmace...

Bristol-Myers Squibb will acquire drug maker Amylin for USD 5.3 billion, a move that will strengthen its position in the diabetic medicines...

Invida Holdings Pvt Ltd today said it has acquired the dermatology and primary care portfolio of Shalaks Pharmaceuticals Pvt Ltd.

GE Healthcare said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedica...

Biocon has fully acquired the joint venture Biocon Biopharmaceuticals from its Cuban partner CIMAB.

Swiss pharmaceutical giant Novartis said it had boosted its stake in biopharmaceutical firm Speedel by 51.7 per cent and aimed to buy it ou...

US-based private equity firm Jacob Ballas Capital (JBC) is close to buying a minority stake in Avestha Gengraine Technologies (Avesthagen),...